Interventional Spine®, Inc. Announces Issuance of Patent No. 8,105,382, Covering the Company’s Unique Expandable Interbody Fusion Device, the Opticage(TM)

IRVINE, Calif., Jan. 31, 2012 /PRNewswire via COMTEX/ — Interventional Spine®, Inc. today announced that the United States Patent Office has issued U.S. Patent No. 8,105,382, entitled Intervertebral Implant. This patent includes key claims that provide patent protection on the Company’s unique expandable interbody fusion device, the Opticage.

Along with the Optiport(TM) access instrumentation, which provides unparalleled percutaneous access to the disc space, the Opticage(TM) is a key component of Interventional Spine’s new PerX360 System(TM). The PerX360 System(TM) provides surgeons the capability of performing a completely percutaneous lumbar interbody fusion procedure via two incisions smaller than 15mm in less than 45 minutes and, if appropriate, under local anesthesia / sedation. This patent significantly strengthens Interventional Spine’s portfolio, placing the Company in the forefront of lumbar fusion technologies intended to significantly reduce surgery times, hospital duration and overall patient pain.

Mr. Walter A. Cuevas, Chief Executive Officer of Interventional Spine, commented “The issuance of this key patent will further cement Interventional Spine’s unique leadership position in providing spinal surgeons the right, forward thinking tools for the next decade. Working together with surgeons from two continents, our engineers have developed a revolutionary technology that, in my opinion, will transform the way the world treats lumbar pain via fusion. We are grateful to all of the contributors who were involved in the development of this system.”

Interventional Spine®, Inc. is the leading innovator of percutaneous technologies in the treatment of back pain with over 12,000 patients being treated to date with the Company’s products worldwide.

Interventional Spine, Inc. is a privately held company based in Irvine, California that designs, develops, and markets patented implantable devices for the spine that can be deployed via percutaneous techniques. Supported by the Company’s unique product introduction systems, Interventional Spine’s products provide benefits to patients, surgeons, and hospitals alike. More information on the Company and its products can be found at: www.i-spineinc.com .

FOR FURTHER INFORMATION CONTACT:Walter A. Cuevas Chief Executive Officer949-472-0006

SOURCE Interventional Spine, Inc